Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 2+2=5

It looks to me like each of them can now hold up to 9.99% of the co. shares and if they sell (to get them back down to 4.99% each) those shares, they have to file with the sec.. I think the reason for the dividends was to allow them to do this. they were also give additional warrants before the conversioin started. PTSC can buy up to 2 million a month--that started in Feb. of '06=22 million should have been bought back by the co. now. I wonder if a 2:1 reverse would automaticaly bring their (S&L) total amount back down to 4.99% or would they have to sell first? At least we will know BEFORE they start selling--if they do. I just don't know if a RS would get them to their desired percentage according to sec rules. There is so much we don't know at this point in time.  Anyway--GL, ads

ps I am certainly not trying to start any RS fud--just trying to figure this all out.

 

Share
New Message
Please login to post a reply